BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 9458170)

  • 1. Peroxisomal disorders: genotype, phenotype, major neuropathologic lesions, and pathogenesis.
    Powers JM; Moser HW
    Brain Pathol; 1998 Jan; 8(1):101-20. PubMed ID: 9458170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Normal and defective neuronal membranes: structure and function: neuronal lesions in peroxisomal disorders.
    Powers JM
    J Mol Neurosci; 2001; 16(2-3):285-7; discussion 317-21. PubMed ID: 11478383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Peroxisomal neurologic diseases and Refsum disease: very long chain fatty acids and phytanic acid as diagnostic markers].
    Molzer B; Stöckler S; Bernheimer H
    Wien Klin Wochenschr; 1992; 104(21):665-70. PubMed ID: 1282286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genotype-phenotype correlations in disorders of peroxisome biogenesis.
    Moser HW
    Mol Genet Metab; 1999 Oct; 68(2):316-27. PubMed ID: 10527683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic heterogeneity of peroxisome biogenesis disorders among Japanese patients: evidence for a founder haplotype for the most common PEX10 gene mutation.
    Shimozawa N; Nagase T; Takemoto Y; Ohura T; Suzuki Y; Kondo N
    Am J Med Genet A; 2003 Jul; 120A(1):40-3. PubMed ID: 12794690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Molecular analysis of peroxisomal disorders].
    Shimozawa N
    No To Hattatsu; 1998 Mar; 30(2):128-33. PubMed ID: 9545777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotype of patients with peroxisomal disorders subdivided into sixteen complementation groups.
    Moser AB; Rasmussen M; Naidu S; Watkins PA; McGuinness M; Hajra AK; Chen G; Raymond G; Liu A; Gordon D
    J Pediatr; 1995 Jul; 127(1):13-22. PubMed ID: 7541833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adrenomyeloneuropathy: a neuropathologic review featuring its noninflammatory myelopathy.
    Powers JM; DeCiero DP; Ito M; Moser AB; Moser HW
    J Neuropathol Exp Neurol; 2000 Feb; 59(2):89-102. PubMed ID: 10749098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peroxisomal disorders.
    Raymond GV
    Curr Opin Pediatr; 1999 Dec; 11(6):572-6. PubMed ID: 10590918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Late onset white matter disease in peroxisome biogenesis disorder.
    Barth PG; Gootjes J; Bode H; Vreken P; Majoie CB; Wanders RJ
    Neurology; 2001 Dec; 57(11):1949-55. PubMed ID: 11769739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroxisomal leukoencephalopathy.
    Poll-The BT; Engelen M
    Semin Neurol; 2012 Feb; 32(1):42-50. PubMed ID: 22422205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peroxisomal disorders.
    Aubourg P; Wanders R
    Handb Clin Neurol; 2013; 113():1593-609. PubMed ID: 23622381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disorders of peroxisome biogenesis due to mutations in PEX1: phenotypes and PEX1 protein levels.
    Walter C; Gootjes J; Mooijer PA; Portsteffen H; Klein C; Waterham HR; Barth PG; Epplen JT; Kunau WH; Wanders RJ; Dodt G
    Am J Hum Genet; 2001 Jul; 69(1):35-48. PubMed ID: 11389485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal profiles of polyunsaturated fatty acids in the brain, liver, kidney and retina of patients with peroxisomal disorders.
    Martinez M
    Brain Res; 1992 Jun; 583(1-2):171-82. PubMed ID: 1504825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peroxisomal disorders I: biochemistry and genetics of peroxisome biogenesis disorders.
    Wanders RJ; Waterham HR
    Clin Genet; 2005 Feb; 67(2):107-33. PubMed ID: 15679822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations in novel peroxin gene PEX26 that cause peroxisome-biogenesis disorders of complementation group 8 provide a genotype-phenotype correlation.
    Matsumoto N; Tamura S; Furuki S; Miyata N; Moser A; Shimozawa N; Moser HW; Suzuki Y; Kondo N; Fujiki Y
    Am J Hum Genet; 2003 Aug; 73(2):233-46. PubMed ID: 12851857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pathology of peroxisomal disorders with pathogenetic considerations.
    Powers JM
    J Neuropathol Exp Neurol; 1995 Sep; 54(5):710-9. PubMed ID: 7666061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of peroxisomal disorders in Japan.
    Suzuki Y; Shimozawa N; Yajima S; Inoue K; Orii T; Kondo N
    Jpn J Hum Genet; 1996 Mar; 41(1):167-75. PubMed ID: 8914632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phytanic acid alpha-oxidation and complementation analysis of classical Refsum and peroxisomal disorders.
    Poll-The BT; Skjeldal OH; Stokke O; Poulos A; Demaugre F; Saudubray JM
    Hum Genet; 1989 Jan; 81(2):175-81. PubMed ID: 2463966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Very-long-chain polyunsaturated fatty acids accumulate in phosphatidylcholine of fibroblasts from patients with Zellweger syndrome and acyl-CoA oxidase1 deficiency.
    Abe Y; Honsho M; Nakanishi H; Taguchi R; Fujiki Y
    Biochim Biophys Acta; 2014 Apr; 1841(4):610-9. PubMed ID: 24418004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.